Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · Real-Time Price · USD
0.5000
-0.0100 (-1.96%)
At close: Apr 17, 2026, 4:00 PM EDT
0.5050
+0.0050 (1.00%)
After-hours: Apr 17, 2026, 7:10 PM EDT

Ensysce Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
541135116
Market Cap Growth
25.38%-61.86%230.93%-30.67%-95.85%-40.93%
Enterprise Value
0.64-0.127.512.745.75120.46
Last Close Price
0.500.928.1415.90135.0016920.00
PE Ratio
--0.23-0.71-0.23-0.06-3.17
PS Ratio
0.920.832.121.501.9132.80
PB Ratio
0.711.312.98-10.33-1.30-14.70
P/TBV Ratio
0.400.731.53-7.43-0.44-12.03
P/FCF Ratio
--0.53-1.47-0.31-0.27-14.05
P/OCF Ratio
--0.54-1.47-0.31-0.27-14.05
EV/Sales Ratio
0.13-0.021.441.232.2834.11
EV/EBITDA Ratio
-0.01-1.36-0.26-0.24-6.37
EV/EBIT Ratio
-0.01-1.12-0.26-0.24-6.06
EV/FCF Ratio
-0.02-1.00-0.25-0.32-14.62
Debt / Equity Ratio
0.110.110.09-1.31-1.09-2.11
Debt / EBITDA Ratio
-0.03-0.03-0.05-0.08-0.18-0.91
Debt / FCF Ratio
-0.04-0.04-0.04-0.08-0.25-2.09
Net Debt / Equity Ratio
-1.25-1.25-0.860.83-0.35-0.63
Net Debt / EBITDA Ratio
0.390.390.580.03-0.05-0.26
Net Debt / FCF Ratio
0.510.510.430.03-0.07-0.60
Asset Turnover
0.780.781.250.520.230.42
Quick Ratio
1.041.041.640.370.360.77
Current Ratio
1.591.592.420.690.560.95
Return on Equity (ROE)
-324.87%-324.87%-585.41%454.03%397.25%393.43%
Return on Assets (ROA)
-156.95%-156.95%-162.07%-249.46%-217.21%-236.99%
Return on Invested Capital (ROIC)
2204.07%2204.07%1911.51%644.37%2435.66%2707.47%
Return on Capital Employed (ROCE)
-326.42%-326.42%-486.78%509.90%1329.61%591.14%
Earnings Yield
-219.36%-432.61%-140.66%-442.77%-1549.11%-31.54%
FCF Yield
-170.94%-188.41%-67.98%-323.25%-371.86%-7.12%
Buyback Yield / Dilution
-266.55%-266.55%-362.24%-1158.33%-114.15%-22.15%
Total Shareholder Return
-266.55%-266.55%-362.24%-1158.33%-114.15%-22.15%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q